246 related articles for article (PubMed ID: 35405594)
1. Viral load is associated with mitochondrial dysfunction and altered monocyte phenotype in acute severe SARS-CoV-2 infection.
Romão PR; Teixeira PC; Schipper L; da Silva I; Santana Filho P; Júnior LCR; Peres A; Gonçalves da Fonseca S; Chagas Monteiro M; Lira FS; Andrey Cipriani Frade M; Comerlato J; Comerlato C; Sant'Anna FH; Bessel M; Abreu CM; Wendland EM; Dorneles GP
Int Immunopharmacol; 2022 Jul; 108():108697. PubMed ID: 35405594
[TBL] [Abstract][Full Text] [Related]
2. A Longitudinal Study of Immune Cells in Severe COVID-19 Patients.
Payen D; Cravat M; Maadadi H; Didelot C; Prosic L; Dupuis C; Losser MR; De Carvalho Bittencourt M
Front Immunol; 2020; 11():580250. PubMed ID: 33178207
[TBL] [Abstract][Full Text] [Related]
3. Endotoxin tolerance and low activation of TLR-4/NF-κB axis in monocytes of COVID-19 patients.
Dorneles GP; Teixeira PC; Peres A; Rodrigues Júnior LC; da Fonseca SG; Monteiro MC; Eller S; Oliveira TF; Wendland EM; Romão PRT
J Mol Med (Berl); 2023 Feb; 101(1-2):183-195. PubMed ID: 36790534
[TBL] [Abstract][Full Text] [Related]
4. An unbalanced PD-L1/CD86 ratio in CD14(++)CD16(+) monocytes is correlated with HCV viremia during chronic HCV infection.
Zheng J; Liang H; Xu C; Xu Q; Zhang T; Shen T; Lu F
Cell Mol Immunol; 2014 May; 11(3):294-304. PubMed ID: 24531620
[TBL] [Abstract][Full Text] [Related]
5. CD14
Urbanski K; Ludew D; Filip G; Filip M; Sagan A; Szczepaniak P; Grudzien G; Sadowski J; Jasiewicz-Honkisz B; Sliwa T; Kapelak B; McGinnigle E; Mikolajczyk T; Guzik TJ
Thromb Haemost; 2017 May; 117(5):971-980. PubMed ID: 28229168
[TBL] [Abstract][Full Text] [Related]
6. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM
Front Immunol; 2021; 12():691725. PubMed ID: 34248984
[TBL] [Abstract][Full Text] [Related]
7. ADAM17-Mediated Reduction in CD14
Waller K; James C; de Jong A; Blackmore L; Ma Y; Stagg A; Kelsell D; O'Dwyer M; Hutchins R; Alazawi W
Front Immunol; 2019; 10():1902. PubMed ID: 31507587
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the CD14++CD16+ monocyte population in human bone marrow.
Mandl M; Schmitz S; Weber C; Hristov M
PLoS One; 2014; 9(11):e112140. PubMed ID: 25369328
[TBL] [Abstract][Full Text] [Related]
9. A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte Subsets.
Ong SM; Teng K; Newell E; Chen H; Chen J; Loy T; Yeo TW; Fink K; Wong SC
Front Immunol; 2019; 10():1761. PubMed ID: 31402918
[TBL] [Abstract][Full Text] [Related]
10. Persistent Oxidative Stress and Inflammasome Activation in CD14
Lage SL; Amaral EP; Hilligan KL; Laidlaw E; Rupert A; Namasivayan S; Rocco J; Galindo F; Kellogg A; Kumar P; Poon R; Wortmann GW; Shannon JP; Hickman HD; Lisco A; Manion M; Sher A; Sereti I
Front Immunol; 2021; 12():799558. PubMed ID: 35095880
[TBL] [Abstract][Full Text] [Related]
11. CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) /CD16(neg) monocytes: Expansion of CD14(hi) /CD16(pos) and contraction of CD14(lo) /CD16(pos) monocytes in acute liver failure.
Abeles RD; McPhail MJ; Sowter D; Antoniades CG; Vergis N; Vijay GK; Xystrakis E; Khamri W; Shawcross DL; Ma Y; Wendon JA; Vergani D
Cytometry A; 2012 Oct; 81(10):823-34. PubMed ID: 22837127
[TBL] [Abstract][Full Text] [Related]
12. The CD14(+/low)CD16(+) monocyte subset is more susceptible to spontaneous and oxidant-induced apoptosis than the CD14(+)CD16(-) subset.
Zhao C; Tan YC; Wong WC; Sem X; Zhang H; Han H; Ong SM; Wong KL; Yeap WH; Sze SK; Kourilsky P; Wong SC
Cell Death Dis; 2010 Nov; 1(11):e95. PubMed ID: 21368871
[TBL] [Abstract][Full Text] [Related]
13. CCR2 Signaling Restricts SARS-CoV-2 Infection.
Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
[TBL] [Abstract][Full Text] [Related]
14. Maximal Exercise Alters the Inflammatory Phenotype and Response of Mononuclear Cells.
Slusher AL; Zúñiga TM; Acevedo EO
Med Sci Sports Exerc; 2018 Apr; 50(4):675-683. PubMed ID: 29112629
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD206 and CD163 on intermediate CD14
Li X; Du N; Xu G; Zhang P; Dang R; Jiang Y; Zhang K
Virus Res; 2018 Jul; 253():92-102. PubMed ID: 29857122
[TBL] [Abstract][Full Text] [Related]
16. The "Intermediate" CD14
Wildgruber M; Aschenbrenner T; Wendorff H; Czubba M; Glinzer A; Haller B; Schiemann M; Zimmermann A; Berger H; Eckstein HH; Meier R; Wohlgemuth WA; Libby P; Zernecke A
Sci Rep; 2016 Dec; 6():39483. PubMed ID: 27991581
[TBL] [Abstract][Full Text] [Related]
17. Blood monocyte profiles in COPD patients with PiMM and PiZZ α1-antitrypsin.
Stolk J; Aggarwal N; Hochnadel I; Wrenger S; Martinez-Delgado B; Welte T; Yevsa T; Janciauskiene S
Respir Med; 2019 Mar; 148():60-62. PubMed ID: 30827477
[TBL] [Abstract][Full Text] [Related]
18. The pro-inflammatory phenotype of the human non-classical monocyte subset is attributed to senescence.
Ong SM; Hadadi E; Dang TM; Yeap WH; Tan CT; Ng TP; Larbi A; Wong SC
Cell Death Dis; 2018 Feb; 9(3):266. PubMed ID: 29449647
[TBL] [Abstract][Full Text] [Related]
19. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
Front Immunol; 2021; 12():746021. PubMed ID: 35082777
[TBL] [Abstract][Full Text] [Related]
20.
Viurcos-Sanabria R; Manjarrez-Reyna AN; Solleiro-Villavicencio H; Rizo-Téllez SA; Méndez-García LA; Viurcos-Sanabria V; González-Sanabria J; Arroyo-Valerio A; Carrillo-Ruíz JD; González-Chávez A; León-Pedroza JI; Flores-Mejía R; Rodríguez-Cortés O; Escobedo G
Front Immunol; 2022; 13():897995. PubMed ID: 35860236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
